Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this location

Wspolczesna Onkologia

Volumn 16, Issue 4, 2012, Pages 310-315

  Waniczek, Dariusz ^a   Śnietura, Mirosław ^b   Pigłowski, Wojciech ^b   Rdes, Jerzy ^a   Kopeć, Agnieszka ^b   Młynarczyk Liszka, Joanna ^b   Rudzki, Marek ^a   Hudyka, Krystyna ^a   Arendt, Jerzy ^a   Lange, Dariusz ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Institute of Oncology   (Poland)

Author keywords

Colorectal cancer; Colorectal polyp; Familial adenomatous polyposis; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE POLYP; LARGE INTESTINE POLYP; MALE; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION;

EID: 84867671901     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2012.30059     Document Type: Article

References (25)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
2. Parsons DW, Wang TL, Samuels Y, et al. Colorectal cancer: mutations in a signalling pathway Nature 2005; 436: 792. (Pubitemid 41160630)
3. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 2008; 8: 187-98. (Pubitemid 351688437)
4. Ali IU, Schriml LM, Dean M. Mutational spektra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 1999; 91: 1922-32.
5. Tian T, Nan KJ, Wang SH, Liang X, Lu ChX, Guo H, Wang WJ, Ruan ZP. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells. Carcinogenesis 2010; 31: 1211-9.
6. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-7. (Pubitemid 27148818)
7. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356-62. (Pubitemid 27147102)
8. Simpkins SB, Peiffer-Schneider S, Mutch DG, et al. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecol Oncol 1998; 71: 391-5. (Pubitemid 29022325)
9. Leslie NR, Downes CP. PTEN function: how normal cells control it and tumour cells lose it. Biochem J 2004; 382: 1-11. (Pubitemid 39141560)
10. Perren A, Weng LP, Boag AH, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999; 155: 1253-60. (Pubitemid 29488932)
11. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Patrol 1986; 10: 871-87. (Pubitemid 17197761)
12. Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell 2008; 133: 403-14. (Pubitemid 351622014)
13. Chu EC, Tarnawski AS. PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit 2004; 10: 235-41.
14. Hlobilková A, Knillová J, Bártek J, et al. The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147: 19-25.
15. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 2004; 303: 1179-81. (Pubitemid 38233580)
16. Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008; 27: 5443-53.
17. Chang CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR. Wu H: PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 2008; 28: 3281-9. (Pubitemid 351657092)
18. Shi W, Zhang X, Pintilie M, et al. Dysregulated PTEN-PKB and negative receptor status in human breast cancer. Int J Cancer 2003; 104: 195-203. (Pubitemid 36249795)
19. Goel A, Arnold CN, Niedzwiecki D, et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 2004; 64: 3014-21. (Pubitemid 38581399)
20. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 2007; 5: 165-70. (Pubitemid 46423997)
21. Flecher RH. Colorectal cancer screening on stronger footning. N Engl J Med 2008; 359: 1285-7.
22. Gilinsky NH, Urlich CD. Colonic Tumores. Endoscopy 1996; 28: 83-106.
23. Waye JD. Polyps large and small. Gastrointest Endosc 1992; 38: 391-6.
24. Ladabaum U, Song K. Projected naarional impaact of colorectal kancer screening on clinical and economic outcomes and healh sevices demands. Gatroenterology 2005; 129: 1151-62. (Pubitemid 41446855)
25. Makinen MJ, George SM, Jernvall P, Makela J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma - prevalence, histological features, and prognosis. J Pathol 2001; 193: 286-94. (Pubitemid 32229858)